Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- INMD -3.2%, DPZ -2.5%
Other news:
- RPAY -20.4% (CFO Tim Murphy will be stepping down)
- TLSI -9.1% (files for 91,263 share common stock offering by selling shareholders, relates to warrants)
- MXCT -6.2% (provides update on proposed cancellation of admission of common stock to trading on AIM)
- AAPG -4.1% (presents results from five preclinical studies at 2025 American Association of Cancer Research Annual Meeting, highlighting strong synergistic effects of Olverembatinib combined with Lisaftoclax)
- YMAB -2.4% (Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting)
- ARVN -1.7% (shares new preclinical combination data for the PROTAC BCL6 Degrader, ARV-393, at the 2025 American Association for Cancer Research Annual Meeting)